// App-Quantinova.ai

BS28 : Ketohexokinase inhibition protects against sucrose-induced endothelial dysfunction and insulin resistance

Researchers

Presenter

  • Hema Viswambharan

Principal Investigators

  • Asjad Visnagri

  • David Bonthron

  • Mark Kearney

Medical Centers

  • LICAMM, University of Leeds, Clarendon Way, Leeds, LDS LS JT United Kingdom, UK

  • Leeds Institute of Medical Research at St James's, University of Leeds

  • Kings College London

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

  • Cardiovascular (CVS)

Disease

  • Vasodilation dysfunction

  • Nonalcoholic fatty liver disease

  • Nonalcoholic steatohepatitis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved